Core Viewpoint - The flu season is experiencing a surge in demand for antiviral medications, with a notable shift towards domestic innovative drugs entering the market, leading to a competitive landscape between traditional imported drugs and new local offerings [1][4][10]. Group 1: Market Dynamics - The flu drug market in China is projected to grow at a compound annual growth rate of 20.2%, potentially reaching a market size of 26.9 billion yuan by 2028 [10]. - The introduction of multiple new domestic antiviral drugs has diversified treatment options for patients, enhancing their ability to respond to the flu [4][6]. - The traditional flu drug, Oseltamivir, has seen its price drop to under 2 yuan per pill due to collective procurement, while new innovative drugs are priced significantly higher, around 200 yuan per pill [7][8]. Group 2: New Drug Developments - Several new antiviral drugs have been approved for clinical use, including innovative RNA polymerase inhibitors like Marbofloxacin and others targeting different mechanisms [5][6]. - The first domestic RNA polymerase PB2 protein inhibitor, Anglave, has been developed, marking a significant advancement in flu treatment options [9][10]. - The market is witnessing a mix of classic and innovative flu medications, with sales of Oseltamivir increasing by 237% recently, while new drugs like Marbofloxacin have also seen substantial sales growth [6][8]. Group 3: Consumer Behavior and Trends - There is a growing awareness and demand for new generation flu medications, although the penetration rate remains low, with less than 5% of patients opting for the new PA-targeted flu drugs [8][9]. - The pediatric market for flu medications is underdeveloped, despite children being significantly more susceptible to flu infections compared to adults [11]. - E-commerce platforms are increasingly playing a crucial role in the distribution of flu medications, providing comprehensive services from home testing to online consultations and drug delivery [11].
流感药“新老混战”:2元一粒的仿制药和200元一粒的原研药同场竞技